Hi All
We've been awaiting the big C word, but as HKP observes with Jubilee, we might not actually hear it. Never mind, there's another big C word in hardmano's post: Confirmation.
Confirmation of everything we've been told and deduced about SNE. It's big. It's commercial. It's on. Big time.
Wouldn't you love to be able to project 12 months ahead to see where we are in April 2016. I've stuck my neck out and predicted only an 18 cent SP at end of 2015, but a big year for shareholders in 2016. Nothing I'm reading now lends me to change my mind on that. My stretch prediction is a $1.20 SP by 2016 year end. Given we'll have some dilution along the way, that might be optimistic. On the other hand, what if:
. SNE does come up 600 with potential appraisal upside?
. A Buried Hills exploratory well makes big find No.3?
. We get a 2C for FAN?
. We do get at least two big investors on board?
. The OP hits $80?
. The $A hits 70?
. The revised plan for Guinea Bisseau turns up SNE mkII?
. And just to throw in a real smokey, Cairn makes a play for FAR?
Is $1.20 optimistic enough?
OOO
- Forums
- ASX - By Stock
- FAR
- COP analysts presentation
COP analysts presentation, page-5
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.0¢ |
Change
-0.005(0.99%) |
Mkt cap ! $46.20M |
Open | High | Low | Value | Volume |
50.5¢ | 50.5¢ | 50.0¢ | $1.708K | 3.383K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 40871 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.5¢ | 2094 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 40871 | 0.500 |
1 | 30000 | 0.495 |
1 | 1995 | 0.485 |
3 | 30930 | 0.480 |
2 | 70000 | 0.475 |
Price($) | Vol. | No. |
---|---|---|
0.505 | 2094 | 3 |
0.510 | 59999 | 2 |
0.515 | 1090 | 1 |
0.525 | 69690 | 1 |
0.530 | 30000 | 1 |
Last trade - 10.15am 15/07/2024 (20 minute delay) ? |
Featured News
FAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online